Skip to main content

Syndeio Biosciences

Indianapolis, United States

Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.

$90.0M raised
May 2025
Venture - Series Unknown

Top Investors

Eli LillyAbbVieCatalio Capital ManagementPalo Santo FundInnoviva

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Syndeio Biosciences

How much funding has Syndeio Biosciences raised?
Syndeio Biosciences has raised $90.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Syndeio Biosciences's investors?
Syndeio Biosciences's investors include Eli Lilly, AbbVie, Catalio Capital Management, Palo Santo Fund, Innoviva.
Where is Syndeio Biosciences headquartered?
Syndeio Biosciences is headquartered in Indianapolis, United States.
What does Syndeio Biosciences do?
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
What stage is Syndeio Biosciences at?
Syndeio Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Syndeio Biosciences — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/syndeio-biosciences. Accessed June 14, 2026.
APA
VCBacked. (2025). Syndeio Biosciences — Funding & Investors. Retrieved June 14, 2026, from https://www.vcbacked.co/company/syndeio-biosciences
Wikipedia (cite web)
{{cite web |title=Syndeio Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/syndeio-biosciences |website=VCBacked |access-date=June 14, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .